4//SEC Filing
Hagen Brett R 4
Accession 0000950170-25-046263
CIK 0001754068other
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 7:19 PM ET
Size
20.8 KB
Accession
0000950170-25-046263
Insider Transaction Report
Form 4
Hagen Brett R
Chief Accounting Officer
Transactions
- Sale
Common Stock
2025-03-26$8.97/sh−907$8,135→ 1,925 total
Footnotes (2)
- [F1]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.70 to $9.60. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2).
Documents
Issuer
Kalaris Therapeutics, Inc.
CIK 0001754068
Entity typeother
Related Parties
1- filerCIK 0001681782
Filing Metadata
- Form type
- 4
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 7:19 PM ET
- Size
- 20.8 KB